Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Johnstone

Showing results (281-290 of 600) with videos related to

Pageof 60
Sort By:
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|September 2, 2006
The Edinburgh High Risk Study: current status and future prospectsEve C Johnstone, Kirsten D Russell, Lesley K Harrison, et al.
Journal of Psychopharmacology (Oxford, England)|January 28, 2012
The Northwick Park 'Functional' Psychosis Study. Phase 2: maintenance treatmentE C Johnstone, T J Crow, D G Owens, et al.
Dalton Transactions (Cambridge, England : 2003)|November 5, 2014
Oxidative halogenation of cisplatin and carboplatin: synthesis, spectroscopy, and crystal and molecular structures of Pt(IV) prodrugsTimothy C Johnstone, Sarah M Alexander, Justin J Wilson, et al.
Dalton Transactions (Cambridge, England : 2003)|August 1, 2007
The synthesis of monomeric terminal lead aryloxides: dependence on reagents and conditionsJ Robin Fulton, Peter B Hitchcock, Nick C Johnstone, et al.
Anaesthesia|August 2, 2020
Associated risks posed to healthcare workers when intubating the trachea of patients with COVID-19: a replyI Ahmad, R Owen, D J N Wong, et al.
New Zealand Veterinary Journal|July 21, 2005
Screening for the Mucopolysaccharidosis-IlIA gene in Huntaway dogsR D Jolly, A C Johnstone, D E Hubbard, et al.
Psychological Medicine|March 9, 2002
Childhood behaviour, psychotic symptoms and psychosis onset in young people at high risk of schizophrenia: early findings from the edinburgh high risk studyP M Miller, M Byrne, A Hodges, et al.
Lancet (London, England)|October 30, 1976
Cerebral ventricular size and cognitive impairment in chronic schizophreniaE C Johnstone, T J Crow, C D Frith, et al.
Drug Discovery Today|March 5, 2013
Designed multiple ligands in metabolic disease research: from concept to platformW Gattrell, C Johnstone, S Patel, et al.
Biological Psychiatry|December 1, 1987
Is there gliosis in schizophrenia? Investigation of the temporal lobeG W Roberts, N Colter, R Lofthouse, et al.
Pageof 60

Showing results (281-290 of 600) with videos related to

Sort By:
Pageof 60
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|September 2, 2006
The Edinburgh High Risk Study: current status and future prospectsEve C Johnstone, Kirsten D Russell, Lesley K Harrison, et al.
Journal of Psychopharmacology (Oxford, England)|January 28, 2012
The Northwick Park 'Functional' Psychosis Study. Phase 2: maintenance treatmentE C Johnstone, T J Crow, D G Owens, et al.
Dalton Transactions (Cambridge, England : 2003)|November 5, 2014
Oxidative halogenation of cisplatin and carboplatin: synthesis, spectroscopy, and crystal and molecular structures of Pt(IV) prodrugsTimothy C Johnstone, Sarah M Alexander, Justin J Wilson, et al.
Dalton Transactions (Cambridge, England : 2003)|August 1, 2007
The synthesis of monomeric terminal lead aryloxides: dependence on reagents and conditionsJ Robin Fulton, Peter B Hitchcock, Nick C Johnstone, et al.
Anaesthesia|August 2, 2020
Associated risks posed to healthcare workers when intubating the trachea of patients with COVID-19: a replyI Ahmad, R Owen, D J N Wong, et al.
New Zealand Veterinary Journal|July 21, 2005
Screening for the Mucopolysaccharidosis-IlIA gene in Huntaway dogsR D Jolly, A C Johnstone, D E Hubbard, et al.
Psychological Medicine|March 9, 2002
Childhood behaviour, psychotic symptoms and psychosis onset in young people at high risk of schizophrenia: early findings from the edinburgh high risk studyP M Miller, M Byrne, A Hodges, et al.
Lancet (London, England)|October 30, 1976
Cerebral ventricular size and cognitive impairment in chronic schizophreniaE C Johnstone, T J Crow, C D Frith, et al.
Drug Discovery Today|March 5, 2013
Designed multiple ligands in metabolic disease research: from concept to platformW Gattrell, C Johnstone, S Patel, et al.
Biological Psychiatry|December 1, 1987
Is there gliosis in schizophrenia? Investigation of the temporal lobeG W Roberts, N Colter, R Lofthouse, et al.
Pageof 60